EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines elicits distinct antibody epitope signatures

Alexander A Cohen, Jennifer R Keeffe, Lusineh Manasyan, Indeever Madireddy, Ange-Célia I Priso Fils, Kim-Marie A Dam, Haley E Stober, Rory A Hills, Woohyun J Moon, Paulo J C Lin, Mark R Howarth, Magnus A G Hoffmann und 1 weitere

Cell Reports · 2026-05 · 45 (5) · 117335

DOI: 10.1016/j.celrep.2026.117335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-05. Verfasst von Alexander A Cohen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Hauptthemen laut MEDLINE: Epitopes, Antibodies, Viral, RNA, Messenger, Viral Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, UK Research and Innovation Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein-based mosaic-8 nanoparticles displaying eight SARS-like betacoronavirus (sarbecovirus) receptor-binding domains (RBDs) elicited broadly cross-reactive antibodies that could protect from zoonotic spillovers. Here, we extend the mosaic-8 concept to mRNA by encoding membrane-bound RBD quartets (four linked RBDs) as dual quartet RBD-mRNA and dual quartet RBD-EABR-mRNA, the latter leveraging ESCRT- and ALIX-binding region (EABR) technology for display on cell surfaces and secreted virus-like particles. Compared with protein-based mosaic-8, mRNA-encoded mosaic-8 induced equivalent or enhanced antibody breadth, neutralization potencies, and conserved epitope targeting, while eliciting enhanced T cell responses and more balanced IgG subclass profiles consistent with potentially superior Fc effector functions. Finally, systems serology-polyclonal epitope mapping (SySPEM) revealed distinct IgG-subclass-specific epitope signatures across mRNA, EABR-mRNA, and protein vaccines, demonstrating that the mode of antigen display can shape epitope recognition. Successful conversion of a multivalent protein vaccine to mRNA platforms informs the design of broadly protective vaccines and advances mosaic-8 toward clinical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpitopesAntibodies, ViralRNA, MessengerViral VaccinesSpike Glycoprotein, CoronavirusSARS-CoV-2AnimalsHumansImmunoglobulin GEpitope MappingProtein DomainsMiceAntibodies, Neutralizing

Stichwörter der Autor:innen

CP: immunologyEABR approachIgG subclassesRBDantibodydeep mutational scanningmosaic-8 RBD nanoparticlespan-sarbecovirus mRNA vaccinepandemic preparednesssystems serology-polyclonal epitope mapping

Substanzen

EpitopesAntibodies, ViralRNA, MessengerImmunoglobulin GViral VaccinesSpike Glycoprotein, CoronavirusAntibodies, Neutralizing

Autor:innen und Institutionen

  • Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
  • Gladstone Institutes, San Francisco, CA 94158, USA.
  • Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, UK; Department of Biochemistry, University of Oxford, OX1 3QU Oxford, UK.
  • Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
  • Department of Pharmacology, University of Cambridge, Tennis Court Road, CB2 1PD Cambridge, UK.
  • Gladstone Institutes, San Francisco, CA 94158, USA; Department of Medicine, University, San Francisco, CA 94143, USA. Electronic address: magnus.hoffmann@gladstone.ucsf.edu.

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • UK Research and Innovation Medical Research Council
  • James B Pendleton Charitable Trust
  • National Institutes of Health
  • California Institute of Technology
  • University of Utah
  • Wellcome Trust

Zitieren

APA

Cohen, A. A., Keeffe, J. R., Manasyan, L., Madireddy, I., Priso Fils, A. I., Dam, K. A., Stober, H. E., Hills, R. A., Moon, W. J., Lin, P. J. C., Howarth, M. R., Hoffmann, M. A. G., & Bjorkman, P. J. (2026). mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines elicits distinct antibody epitope signatures. Cell Reports, 45(5), 117335. https://doi.org/10.1016/j.celrep.2026.117335

Vancouver

Cohen AA, Keeffe JR, Manasyan L, Madireddy I, Priso Fils AI, Dam KA, et al. mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines elicits distinct antibody epitope signatures. Cell Reports. 2026;45(5):117335. doi:10.1016/j.celrep.2026.117335

BibTeX
@article{Cohen2026,
  author = {Cohen, Alexander A and Keeffe, Jennifer R and Manasyan, Lusineh and Madireddy, Indeever and Priso Fils, Ange-Célia I and Dam, Kim-Marie A and Stober, Haley E and Hills, Rory A and Moon, Woohyun J and Lin, Paulo J C and Howarth, Mark R and Hoffmann, Magnus A G and Bjorkman, Pamela J},
  title = {mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines elicits distinct antibody epitope signatures},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {5},
  pages = {117335},
  doi = {10.1016/j.celrep.2026.117335}
}
Kostenlos starten →